TP53 mutations and breast cancer prognosis: Particularly poor survival rates for cases with mutations in the zinc-binding domains-Reference-Cited by-同舟云学术

TP53 mutations and breast cancer prognosis: Particularly poor survival rates for cases with mutations in the zinc-binding domains

Published:1995-09 Issue:1 Volume:14 Page:71-75
ISSN:1045-2257
Container-title:Genes, Chromosomes and Cancer
language:en
Short-container-title:Genes Chromosom. Cancer

Author:

Børresen Anne-Lise,Andersen Tone Ikdahl,Eyfjörd Jorunn E.,Cornelis Renee S.,Thorlacius Steinunn,Borg Åke,Johansson Ulla,Theillet Charles,Scherneck Siegfried,Hartman Susanne,Cornelisse Cees J.,Hovig Eivind,Devilee Peter

Publisher

Wiley

Subject

Cancer Research,Genetics

Reference10 articles.

1. (1995) Alterations of the TP53 gene as a potential molecular marker in breast carcinomas; advantages of using CDGE in mutation detection. Diagn Mol Pathol (in press).

2. Prognostic significance of TP53 alterations in breast carcinoma

3. Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Osimertinib treatment response in a patient with lung adenocarcinoma harboring two rare EGFR mutations: A case report;Oncology Letters;2024-08-16

2. Outcomes of De Novo Oligometastatic Breast Cancer Treated With Surgery of Primary and Metastasis Directed Radiotherapy;American Journal of Clinical Oncology;2024-07-04

3. BAG2 drives chemoresistance of breast cancer by exacerbating mutant p53 aggregate;Theranostics;2023

4. Comprehensive Analysis of Transcriptomics and Genetic Alterations Identifies Potential Mechanisms Underlying Anthracycline Therapy Resistance in Breast Cancer;Biomolecules;2022-12-08

5. Clinical spectrum and prognostic value of TP53 mutations in circulating tumor DNA from breast cancer patients in China;Cancer Communications;2020-05-21